Brain-specific fatty acid-binding protein is elevated in serum of patients with dementia-related diseases: Brain-specific fatty acid-binding protein in dementia

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599 · see citing works

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863 · see citing works

Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets

Furuhashi, M., & Hotamışlıgil, G. S. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2589 · Cited by 1,771 · see citing works

CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment

Mattsson, N. (2009) · JAMA · doi:10.1001/jama.2009.1064 · Cited by 1,176 · see citing works

The multigene family of fatty acid-binding proteins (FABPs): Function, structure and polymorphism

Chmurzyńska, A. (2006) · Journal of Applied Genetics · doi:10.1007/bf03194597 · Cited by 744 · see citing works

Decreased β-Amyloid_1-42and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease

Sunderland, T., Linker, G., Mirza, N., Putnam, K. T., Friedman, D. L., Kimmel, L. H., Bergeson, J., Manetti, G. J., Zimmermann, M., Tang, B., et al. (2003) · JAMA · doi:10.1001/jama.289.16.2094 · Cited by 656 · see citing works

Cellular fatty acid-binding proteins: Their function and physiological significance

Glatz, J. F. C., & Vusse, G. J. (1996) · Progress in Lipid Research · doi:10.1016/s0163-7827(96)00006-9 · Cited by 567 · see citing works

The fatty acid transport function of fatty acid-binding proteins

Storch, J., & THUMSER, A. E. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00046-9 · Cited by 530 · see citing works

Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors α- and γ-mediated gene expression via liver fatty acid binding protein: A signaling path to the nucleus

Wolfrum, C., Borrmann, C. M., Börchers, T., & Spener, F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051619898 · Cited by 503 · see citing works

Fatty acid-binding proteins as plasma markers of tissue injury

Pelsers, M. M. A. L., Hermens, W. T., & Glatz, J. F. C. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.09.001 · Cited by 488 · see citing works

Plasma Aβ1–40 and Aβ1–42 and the risk of dementia: a prospective case-cohort study

van Oijen, M., Hofman, A., Soares, H. D., Koudstaal, P. J., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70501-4 · Cited by 458 · see citing works

Association of Low Plasma Aβ42/Aβ40 Ratios With Increased Imminent Risk for Mild Cognitive Impairment and Alzheimer Disease

Graff‐Radford, N. R., Crook, J. E., Lucas, J. A., Boeve, B. F., Knopman, D. S., Ivnik, R. J., Smith, G. E., Younkin, L. H., Petersen, R. C., & Younkin, S. G. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.354 · Cited by 441 · see citing works

The expression pattern of a novel gene encoding brain-fatty acid binding protein correlates with neuronal and glial cell development

Kurtz, A., Zimmer, A. D., Schnütgen, F., Brüning, G., Spener, F., & Müller, T. H. (1994) · Development · doi:10.1242/dev.120.9.2637 · Cited by 369 · see citing works

A Specific Enzyme-Linked Immunosorbent Assay for Measuring β-Amyloid Protein Oligomers in Human Plasma and Brain Tissue of Patients With Alzheimer Disease

Xia, W., Yang, T., Shankar, G. M., Smith, I. M., Shen, Y., Walsh, D. M., & Selkoe, D. J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.565 · Cited by 215 · see citing works

Impaired Long-Chain Fatty Acid Utilization by Cardiac Myocytes Isolated From Mice Lacking the Heart-Type Fatty Acid Binding Protein Gene

Schaap, F. G., Binas, B., Danneberg, H., Vusse, G. J., & Glatz, J. F. C. (1999) · Circulation Research · doi:10.1161/01.res.85.4.329 · Cited by 208 · see citing works

CSF biomarkers predict rate of cognitive decline in Alzheimer disease

Kester, M. I., van der Vlies, A. E., Blankenstein, M. A., Pijnenburg, Y. A. L., van Elk, E. J., Scheltens, P., & van der Flier, W. M. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bd8271 · Cited by 158 · see citing works

Fatty Acid Binding Protein as a Serum Marker for the Early Diagnosis of Stroke

Zimmermann‐Ivol, C. G., Burkhard, P. R., Floch-Rohr, J. L., Allard, L., Hochstrasser, D. F., & Sanchez, J. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300066-mcp200 · Cited by 145 · see citing works

Brain- and Heart-Type Fatty Acid-Binding Proteins in the Brain: Tissue Distribution and Clinical Utility

Pelsers, M. M. A. L., Hanhoff, T., van der Voort, D., Arts, B. M. G., Peters, M. J. V., Ponds, R., Honig, A., Rudzinski, W., Spener, F., de Kruijk, J. R., et al. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.030361 · Cited by 125 · see citing works

[The Maastricht aging study (MAAS). The longitudinal perspective of cognitive aging].

Jolles, J., van Boxtel, M. P. J., Ponds, R., Metsemakers, J. F. M., & Houx, P. J. (1998) · PubMed · Cited by 124 · see citing works

One-Step Enzyme-Linked Immunosorbent Assay (ELISA) for Plasma Fatty Acid-Binding Protein

Wodzig, K. W. H., Pelsers, M. M. A. L., Vusse, G. J., Roos, W., & Glatz, J. F. C. (1997) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329703400307 · Cited by 115 · see citing works

Release of brain–type and heart–type fatty acid–binding proteins in serum after acute ischaemic stroke

Wunderlich, M., Hanhoff, T., Goertler, M., Spener, F., Glatz, J. F. C., Wallesch, C.-W., & Pelsers, M. M. A. L. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0725-z · Cited by 102 · see citing works

Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing

Lewczuk, P., Kornhuber, J., Vanmechelen, E., Peters, O., Heuser, I., Maier, W., Jessen, F., Bürger, K., Hampel, H. J., Frölich, L., et al. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.024 · Cited by 102 · see citing works

Elevated Plasma β-Amyloid Peptide Aβ42 Levels, Incident Dementia, and Mortality in Down Syndrome

Schupf, N., Patel, B. N., Pang, D. I., Zigman, W. B., Silverman, W. P., Mehta, P. D., & Mayeux, R. P. (2007) · Archives of Neurology · doi:10.1001/archneur.64.7.1007 · Cited by 100 · see citing works

Combination of serum markers related to several mechanisms in Alzheimer’s disease

Teunissen, C. E., Lütjohann, D., von Bergmann, K., Verhey, F. R. J., Vreeling, F. W., Wauters, A., Bosmans, E., Bosma, H., van Boxtel, M. P. J., Maes, M. H. J., et al. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00005-8 · Cited by 95 · see citing works

Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases

Steinacker, P., Mollenhauer, B., Bibl, M., Cepek, L., Esselmann, H., Brechlin, P., Lewczuk, P., Poser, S., Kretzschmar, H. A., Wiltfang, J., et al. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.07.061 · Cited by 85 · see citing works

Diagnosing dementia: a comparison between a monodisciplinary and a multidisciplinary approach

Verhey, F. R. J., Jolles, J., Ponds, R., Rozendaal, N., Plugge, L. A., de Vet, R. C., Vreeling, F. W., & van der Lugt, P. J. M. (1993) · Journal of Neuropsychiatry · doi:10.1176/jnp.5.1.78 · Cited by 84 · see citing works

Serum Heart-Type Fatty Acid-Binding Protein and Cerebrospinal Fluid Tau: Marker Candidates for Dementia with Lewy Bodies

Mollenhauer, B., Steinacker, P., Bahn, E., Bibl, M., Brechlin, P., Schlossmacher, M. G., Locascio, J. J., Wiltfang, J., Kretzschmar, H. A., Poser, S., et al. (2007) · Neurodegenerative Diseases · doi:10.1159/000105157 · Cited by 81 · see citing works

A potential cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt‐Jakob disease

Guillaume, E., Zimmermann, C., Burkhard, P. R., Hochstrasser, D. F., & Sanchez, J. (2003) · PROTEOMICS · doi:10.1002/pmic.200300478 · Cited by 80 · see citing works

Influence of age and sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects.

Pelsers, M. M. A. L., Chapelle, J.-P., Knapen, M. H. J., Vermeer, C., Muijtjens, A. M. M., Hermens, W. T., & Glatz, J. F. C. (1999) · PubMed · Cited by 75 · see citing works

Serum heart-fatty acid binding protein levels in patients with Lewy body disease

Wada‐Isoe, K., Imamura, K., Michio, K., Kowa, H., & Nakashima, K. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.08.018 · Cited by 42 · see citing works

Prevalence of primitive reflexes and the relationship with cognitive change in healthy adults

van Boxtel, M. P. J., Bosma, H., Jolles, J., & Vreeling, F. W. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0138-7 · Cited by 41 · see citing works

Detection of brain injury by fatty acid-binding proteins

Pelsers, M. M. A. L., & Glatz, J. F. C. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.135 · Cited by 36 · see citing works

Collision-Mediated Transfer of Long-Chain Fatty Acids by Neural Tissue Fatty Acid-Binding Proteins (FABP): Studies with Fluorescent Analogs

THUMSER, A. E. A., Tsai, J., & Storch, J. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:16:2-3:143 · Cited by 34 · see citing works

A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain

Wang, J., Gu, B. J., Masters, C. L., & Wang, Y.-J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.111 · Cited by 808 · see citing works

An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders

Ashton, N. J., Hye, A., Rajkumar, A. P., Leuzy, A., Snowden, S. G., Suárez‐Calvet, M., Karikari, T. K., Schöll, M., Joie, R. L., Rabinovici, G. D., et al. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0348-0 · Cited by 182 · see citing works

A Blood-Based Screening Tool for Alzheimer's Disease That Spans Serum and Plasma: Findings from TARC and ADNI

O’Bryant, S. E., Xiao, G., Barber, R. C., Huebinger, R. M., Wilhelmsen, K. C., Edwards, M., Graff‐Radford, N. R., Doody, R. S., Diaz-Arrastia, R. R., & Initiative, A. D. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028092 · Cited by 156 · see citing works

Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology

Baird, A. L., Westwood, S., & Lovestone, S. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00236 · Cited by 118 · see citing works

Fatty acids and evolving roles of their proteins in neurological, cardiovascular disorders and cancers

Mallick, R., Basak, S., & Duttaroy, A. K. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101116 · Cited by 117 · see citing works

The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injury

Plomgaard, A. M., van Oeveren, W., Petersen, T. H., Alderliesten, T., Austin, T., van Bel, F., Benders, M. J. N. L., Claris, O., Dempsey, E. M., Franz, A. R., et al. (2015) · Pediatric Research · doi:10.1038/pr.2015.266 · Cited by 80 · see citing works

Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer’s pathology: Insights and therapeutic approaches from periphery

Ullah, R., Park, T. J., Huang, X., & Kim, M. O. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101451 · Cited by 78 · see citing works

Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia

Kawahata, I., & Fukunaga, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113779 · Cited by 71 · see citing works

Fatty acid transporting proteins: Roles in brain development, aging, and stroke

Zhang, W., Chen, R., Yang, T., Xu, N., Chen, J., Gao, Y., & Stetler, R. A. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.04.004 · Cited by 74 · see citing works

Neuronal damage biomarkers in the identification of patients at risk of long‐term postoperative cognitive dysfunction after cardiac surgery

Kok, W. F., Koerts, J., Tucha, O. M., Scheeren, T., & Absalom, A. R. (2016) · Anaesthesia · doi:10.1111/anae.13712 · Cited by 73 · see citing works

Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial

Plomgaard, A. M., Alderliesten, T., Austin, T., van Bel, F., Benders, M. J. N. L., Claris, O., Dempsey, E. M., Fumagalli, M., Gluud, C. N., Hagmann, C. F., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173440 · Cited by 64 · see citing works

Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases

Mayo, S., Benito‐León, J., Peña‐Bautista, C., Baquero, M., & Cháfer‐Pericás, C. (2020) · Current Neuropharmacology · doi:10.2174/1570159x19666201223154009 · Cited by 60 · see citing works

Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer’s disease: results from the DELCODE study

Brosseron, F., Maaß, A., Kleineidam, L., Ravichandran, K. A., Kolbe, C., Wolfsgruber, S., Santarelli, F., Häsler, L. M., McManus, R. M., Ising, C., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01118-0 · Cited by 61 · see citing works

Fatty acid-binding proteins 3 and 5 are involved in the initiation of mitochondrial damage in ischemic neurons

Guo, Q., Kawahata, K., Cheng, A., Wang, H., Jia, W., Yoshino, H., & Fukunaga, K. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102547 · Cited by 58 · see citing works

Overview of the blood biomarkers in Alzheimer's disease: Promises and challenges

Delaby, C., Hirtz, C., & Lehmann, S. (2022) · Revue Neurologique · doi:10.1016/j.neurol.2022.09.003 · Cited by 56 · see citing works

Identifying amyloid pathology–related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study

Leung, Y. Y., Toledo, J. B., Nefedov, A., Robi Polikar, A., Raghavan, N., Xie, S. X., Farnum, M. A., Schultz, T., Baek, Y., Deerlin, V. M. V., et al. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.06.008 · Cited by 46 · see citing works

Astroglial DJ-1 over-expression up-regulates proteins involved in redox regulation and is neuroprotective in vivo

Frøyset, A. K., Edson, A. J., Gharbi, N., Khan, E. A., Dondorp, D. C., Bai, Q., Tiraboschi, E., Suster, M. L., Connolly, J. B., Burton, E. A., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.02.010 · Cited by 43 · see citing works

FABP7 drives an inflammatory response in human astrocytes and is upregulated in Alzheimer’s disease

Hamilton, H. L., Kinscherf, N. A., Balmer, G., Bresque, M., Salamat, S. M., Vargas, M. R., & Pehar, M. (2023) · GeroScience · doi:10.1007/s11357-023-00916-0 · Cited by 41 · see citing works

Amyloid‐β induces sleep fragmentation that is rescued by fatty acid binding proteins in <i>Drosophila</i>

Gerstner, J. R., Lenz, O., Vanderheyden, W. M., Chan, M. T., Pfeiffenberger, C., & Pack, A. I. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23778 · Cited by 40 · see citing works

Efficient and biologically relevant consensus strategy for Parkinson’s disease gene prioritization

Cruz‐Monteagudo, M., Borges, F., Paz‐y‐Miño, C., Cordeiro, M. N. D. S., Rebelo, I., Pérez‐Castillo, Y., Helguera, A. M., Sánchez‐Rodríguez, A., & Tejera, E. (2016) · BMC Medical Genomics · doi:10.1186/s12920-016-0173-x · Cited by 37 · see citing works

Role of FABP3 as Biomarker in Alzheimer's Disease and Synucleinopathies

Sepe, F. N., Chiasserini, D., & Parnetti, L. (2018) · Future Neurology · doi:10.2217/fnl-2018-0003 · Cited by 38 · see citing works

Lipid chaperones and associated diseases: a group of chaperonopathies defining a new nosological entity with implications for medical research and practice

D’Anneo, A., Bavisotto, C. C., Marino, A., Paladino, L., Carlisi, D., Cappello, F., de Macario, E. C., Macario, A. J. L., & Lauricella, M. (2020) · Cell Stress and Chaperones · doi:10.1007/s12192-020-01153-6 · Cited by 35 · see citing works

Fatty-Acid-Binding Proteins: From Lipid Transporters to Disease Biomarkers

Gaffar, S., & Aathirah, A. S. (2023) · Biomolecules · doi:10.3390/biom13121753 · Cited by 35 · see citing works

Fatty Acid-Binding Proteins Aggravate Cerebral Ischemia-Reperfusion Injury in Mice

Guo, Q., Kawahata, K., Degawa, T., Ikeda‐Matsuo, Y., Sun, M., Han, F., & Fukunaga, K. (2021) · Biomedicines · doi:10.3390/biomedicines9050529 · Cited by 34 · see citing works

Dopamine D2 Long Receptors Are Critical for Caveolae-Mediated α-Synuclein Uptake in Cultured Dopaminergic Neurons

Kawahata, K., Sekimori, T., Wang, H., Wang, Y., Sasaoka, T., Bousset, L., Melki, R., Mizobata, T., Kawata, Y., & Fukunaga, K. (2021) · Biomedicines · doi:10.3390/biomedicines9010049 · Cited by 32 · see citing works

Fatty acid-binding protein 7 triggers α-synuclein oligomerization in glial cells and oligodendrocytes associated with oxidative stress

Cheng, A., Wang, Y., Shinoda, Y., Kawahata, K., Yamamoto, T., Jia, W., Yamamoto, H., Mizobata, T., Kawata, Y., & Fukunaga, K. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00675-8 · Cited by 32 · see citing works

Role of astrocytes in sleep deprivation: accomplices, resisters, or bystanders?

Que, M., Li, Y., Wang, X., Zhan, G., Luo, X., & Zhou, Z. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1188306 · Cited by 33 · see citing works

Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease

Gangishetti, U., Howell, J. C., Perrin, R. J., Louneva, N., Watts, K. D., Kollhoff, A. L., Grossman, M., Wolk, D. A., Shaw, L. M. J., Morris, J. C., et al. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0426-3 · Cited by 30 · see citing works

Fatty Acid Binding Protein 3 (FABP3) and Apolipoprotein E4 (ApoE4) as Lipid Metabolism-Related Biomarkers of Alzheimer’s Disease

Dulewicz, M., Kulczyńska‐Przybik, A., Słowik, A., Borawska, R., & Mroczko, B. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10143009 · Cited by 28 · see citing works

A Dichotomous Role for FABP7 in Sleep and Alzheimer’s Disease Pathogenesis: A Hypothesis

Needham, H., Torpey, G., Flores, C. C., Davis, C. J., Vanderheyden, W. M., & Gerstner, J. R. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.798994 · Cited by 28 · see citing works

Fatty Acid-Binding Proteins: Their Roles in Ischemic Stroke and Potential as Drug Targets

Guo, Q., Kawahata, K., Cheng, A., Jia, W., Wang, H., & Fukunaga, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179648 · Cited by 27 · see citing works

Transcriptomic Insights into the Response of the Olfactory Bulb to Selenium Treatment in a Mouse Model of Alzheimer’s Disease

Zheng, R., Zhang, Z.-H., Zhao, Y., Chen, C., Jia, S.-Z., Cao, X.-C., Shen, L., Ni, J., & Song, G.-L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122998 · Cited by 22 · see citing works

Fatty Acid-Binding Protein 3 Expression in the Brain and Skin in Human Synucleinopathies

Oizumi, H., Yamasaki, K., Suzuki, H., Hasegawa, T., Sugimura, Y., Baba, T., Fukunaga, K., & Takeda, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.648982 · Cited by 22 · see citing works

FABP7: a glial integrator of sleep, circadian rhythms, plasticity, and metabolic function

Gerstner, J. R., Flores, C. C., Lefton, M., Rogers, B., & Davis, C. J. (2023) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2023.1212213 · Cited by 22 · see citing works

Impact of Fatty Acid-Binding Proteins in α-Synuclein-Induced Mitochondrial Injury in Synucleinopathy

Cheng, A., Jia, W., Kawahata, K., & Fukunaga, K. (2021) · Biomedicines · doi:10.3390/biomedicines9050560 · Cited by 20 · see citing works

Pathogenic Impact of Fatty Acid-Binding Proteins in Parkinson’s Disease—Potential Biomarkers and Therapeutic Targets

Kawahata, K., & Fukunaga, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242317037 · Cited by 18 · see citing works

The transcriptional repressor Rev-erbα regulates circadian expression of the astrocyte Fabp7 mRNA

Vanderheyden, W. M., Fang, B., Flores, C. C., Jager, J., & Gerstner, J. R. (2021) · Current Research in Neurobiology · doi:10.1016/j.crneur.2021.100009 · Cited by 14 · see citing works

Glia: the cellular glue that binds circadian rhythms and sleep

Carvalhas-Almeida, C., & Sehgal, A. (2025) · SLEEP · doi:10.1093/sleep/zsae314 · Cited by 14 · see citing works

Parkinson disease is a fatty acidopathy

Fanning, S., & Selkoe, D. J. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01142-2 · Cited by 13 · see citing works

Role of CSF Biomarkers in the Diagnosis of Prodromal Alzheimer‘s Disease

Parnetti, L., & Chiasserini, D. (2011) · Biomarkers in Medicine · doi:10.2217/bmm.11.48 · Cited by 12 · see citing works

Plasma fatty acid-binding protein 7 concentration correlates with depression/anxiety, cognition, and positive symptom in patients with schizophrenia

Koga, M., Nakagawa, S., Sato, A., Oka, M., Makihara, K., Sakai, Y., Toyomaki, A., Sato, M., Matsui, M., Toda, H., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.10.028 · Cited by 12 · see citing works

Fatty Acid-Binding Protein 7 (FABP-7), Glutamic Acid and Neurofilament Light Chain (NFL) as Potential Markers of Neurodegenerative Disorders in Psoriatic Patients—A Pilot Study

Nowowiejska, J., Baran, A. M., Hermanowicz, J. M., Sieklucka, B., Krahel, J. A., Kiluk, P., Pawlak, D., & Flisiak, I. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092430 · Cited by 12 · see citing works

Fatty acid–binding proteins 3, 7, and 8 bind cholesterol and facilitate its egress from lysosomes

Fang, X.-X., Wei, P., Zhao, K., Sheng, Z.-C., Song, B., Yin, L., & Luo, J. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202211062 · Cited by 10 · see citing works

Pathology and Treatments of Alzheimer’s Disease Based on Considering Changes in Brain Energy Metabolism Due to Type 2 Diabetes

Yanai, H., Adachi, H., Hakoshima, M., & Katsuyama, H. (2024) · Molecules · doi:10.3390/molecules29245936 · Cited by 11 · see citing works

The Correlations of Plasma Liver-Type Fatty Acid-Binding Protein with Amyloid-β and Tau Levels in Patients with Alzheimer’s Disease

Cheng, Y., Jian, J.-M., He, C.-Y., Ren, J.-R., Xu, M., Jin, W., Tan, C., Zeng, G., Shen, Y., Chen, D., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220126 · Cited by 10 · see citing works

Targeting the FABP Axis: Interplay Between Lipid Metabolism, Neuroinflammation, and Neurodegeneration

Wu, C., Lin, J., Chen, Q., Zhao, W., Kawahata, K., & Cheng, A. (2025) · Cells · doi:10.3390/cells14191502 · Cited by 9 · see citing works

The Role of Fatty Acid Binding Protein 7 in Neurological Diseases

Chen, Y., Liu, J., He, Y., Yang, L., & Yu, W. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05071-5 · Cited by 8 · see citing works

Pleiotropic Effect of Human ApoE4 on Cerebral Ceramide and Saturated Fatty Acid Levels

den Hoedt, S., Janssen, C. I. F., Astarita, G., Piomelli, D., Leijten, F. P. J., Crivelli, S. M., Verhoeven, A. J. M., de Vries, H. E., Walter, J., Martínez‐Martínez, P., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160739 · Cited by 8 · see citing works

Exploring Potential Biomarkers Underlying Pathogenesis of Alzheimer's Disease by Differential Co-expression Analysis.

Izadi, F., & Soheilifar, M. H. (2018) · Europe PMC (PubMed Central) · Cited by 6 · see citing works

Advances in Blood Biomarkers and Diagnosis Approaches for Neurodegenerative Dementias and Related Diseases

Sekimori, T., Fukunaga, K., Finkelstein, D. I., & Kawahata, K. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2310188 · Cited by 6 · see citing works

Circulating adipokines and MRI markers of brain aging in middle-aged adults from the community

Satizábal, C. L., Himali, J. J., Conner, S. C., Beiser, A., Maillard, P., Vasan, R. S., DeCarli, C. S., & Seshadri, S. S. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241289043 · Cited by 6 · see citing works

Fatty acid binding protein as a new age biomarker

Shand, H., Patra, S., & Ghorai, S. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.120029 · Cited by 6 · see citing works

FABP7 is increased in progressive multiple sclerosis and induces a pro-inflammatory phenotype in monocytes through a glycolytic switch

Patel, R. P., King, D. A., LaBarre, B. A., Lokhande, H. A., Caefer, D., Varghese, J. F., Warner, K., Bouffard, M. A., Saxena, S., Zhirova, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60747-9 · Cited by 6 · see citing works

Dysregulation of Lipid Metabolism Serves as A Link Between Alzheimer’s and Cardiovascular Disease, As Witnessed in A Cross-Sectional Study

Mouriño-Álvarez, L., Juárez-Alia, C., Sastre-Oliva, T., Perales-Sánchez, I., Hernández-Fernández, G., Chicano‐Gálvez, E., Peralbo‐Molina, Á., Madruga, F., Blanco-López, E., Tejerina, T., et al. (2024) · Aging and Disease · doi:10.14336/ad.2024.0434 · Cited by 6 · see citing works

The Role of Fatty Acid Binding Proteins in Neuropsychiatric Diseases: A Narrative Review

Powell, A., Yamaguchi, N., Lu, H., Pareek, O., Elman, I., Gold, M. S., Pinhasov, A., Blum, K., & Thanos, P. K. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl26812 · Cited by 5 · see citing works

Astrocyte arachidonate and palmitate uptake and metabolism is differentially modulated by dibutyryl-cAMP treatment

Seeger, D. R., Murphy, C. C., & Murphy, E. J. (2016) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2016.05.003 · Cited by 4 · see citing works

The association between FABP7 serum levels with survival and neurological complications in acetaminophen-induced acute liver failure: a nested case–control study

Karvellas, C. J., Speiser, J. L., Tremblay, M., Lee, W. M., & Rose, C. F. (2017) · Annals of Intensive Care · doi:10.1186/s13613-017-0323-0 · Cited by 4 · see citing works

Fatty acid binding proteins-mediated mitochondrial dysfunction in the development of age-related diseases: A review

Ren, X., Jin, C., Li, Q., Fu, C., Yu, F., Xu, Z., Liang, Z., & Wang, T. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142913 · Cited by 3 · see citing works

Vers un diagnostic biologique sanguin de la maladie d’Alzheimer ?

Delaby, C., & Lehmann, S. (2024) · médecine/sciences · doi:10.1051/medsci/2024037 · Cited by 3 · see citing works

FABP7 Expression Modulates the Response of Astrocytes to Induced Endotoxemia

Bresque, M., Esteve, D., Balmer, G., Hamilton, H., Stephany, J. S., Pehar, M., & Vargas, M. R. (2025) · Glia · doi:10.1002/glia.70023 · Cited by 3 · see citing works

Protective Effect of FABP5 Against 6-OHDA Induced Parkinson’s Disease Via PPARγ/SIRT1/PGC-1α Signaling Pathway

Ni, Y., Hayat, M. A., Si, Y., Guo, T., Zhang, J., Hong, Y., Cao, Y., He, S., Weng, Z., Li, F., et al. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04422-x · Cited by 2 · see citing works

Galantamine therapy for alzheimer’s disease by introducing nanodrug delivery systems

Bakry, S. E., & Mostapha, W. (2016) · Egyptian Journal of Psychiatry · doi:10.4103/1110-1105.193013 · Cited by 2 · see citing works

Advances in neurology 2011–12

Schapira, A. H. V., & Hillbom, M. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03870.x · Cited by 1 · see citing works

The Role of Osteopontin in Psoriasis—A Scoping Review

Kimak-Pielas, A., & Woźniacka, A. J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030655 · Cited by 2 · see citing works

Znaczenie kliniczne białek wiążących kwasy tłuszczowe (FABPs) The clinical significance of fatty acid binding proteins

Choromańska, B., Dadan, J., Hady, H. R., & Chabowski, A. (2011) · Cited by 1 · see citing works

High serum levels of fatty acid–binding protein 7 in diabetic rats with experimental sepsis

Martins, E. D. P. A., de Lima, T. M., Barbeiro, H. V., Machado, M. C. C., & da Silva, F. P. (2018) · European Journal of Inflammation · doi:10.1177/2058739218764235

Role of fatty acid-binding protein 7 and novel therapeutic approach in synucleinopathies

Cheng, A., & Fukunaga, K. (2022) · Folia Pharmacologica Japonica · doi:10.1254/fpj.22056

Clinical effect of carotid stenting on cognitive abilities - possible evaluation using candidates for biomarkers

Yaneva-Sirakova, T., Vassilev, D. I., Karamfiloff, K. K., Hristova, J., Shumkova, M., & Traykov, L. D. (2023) · Folia Medica · doi:10.3897/folmed.65.e79996

The level of dementia biomarkers in type 2 diabetes mellitus

Özpak, L., Şahin, M., ÇELİK, İ. S., KELLECİ, B. M., & Çelik, M. (2023) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.1311596

Roles of fatty acid-binding proteins in brain inflammation

Duttaroy, A. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95700-7.00023-1

Fatty acid-binding proteins and brain diseases

Duttaroy, A. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95700-7.00011-5

Fatty acid-binding proteins as therapeutic targets in different diseases

Duttaroy, A. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95700-7.00004-8

Additional file 1 of Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer’s disease: results from the DELCODE study

Brosseron, F., Maaß, A., Kleineidam, L., Ravichandran, K. A., Kolbe, C.-C., Wolfsgruber, S., Santarelli, F., Häsler, L. M., McManus, R. M., Ising, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22602371

Mid-life candidate vascular plasma biomarkers are associated with MRI markers of vascular brain injury and amyloid- and tau-PET in cognitively healthy adults

Mulligan, M. D., Wang, R., Yang, Q., Beiser, A., Maillard, P., Satizábal, C. L., Ghosh, S., Tanner, J. A., Johnson, K. A., DeCarli, C. S., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261480733

Serum Heart-Type Fatty Acid-Binding Protein and Cerebrospinal Fluid Tau: Marker Candidates for Dementia with Lewy Bodies

Mollenhauer, B., Steinacker, P., Bahn, E., Bibl, M., Brechlin, P., Schlossmacher, M. G., Locascio, J. J., Wiltfang, J., Kretzschmar, H. A., Poser, S., et al. (2007) · Neurodegenerative Diseases · doi:10.1159/000105157 · Cited by 81 · see citing works

Heart type fatty acid binding protein (H-FABP) is decreased in brains of patients with Down syndrome and Alzheimer’s disease

Cheon, M. S., Kim, S. H., Fountoulakis, M., & Lübec, G. (2003) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6721-2_20 · Cited by 53 · see citing works

Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases

Steinacker, P., Mollenhauer, B., Bibl, M., Cepek, L., Esselmann, H., Brechlin, P., Lewczuk, P., Poser, S., Kretzschmar, H. A., Wiltfang, J., et al. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.07.061 · Cited by 85 · see citing works

Cerebrospinal Fluid Levels of Heart Fatty Acid Binding Protein are Elevated Prodromally in Alzheimer's Disease and Vascular Dementia

Olsson, B., Hertze, J., Ohlsson, M., Nägga, K., Höglund, K., Basun, H., Annas, P., Lannfelt, L., Andreasen, N., Minthon, L., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121384 · Cited by 46 · see citing works

CSF levels of heart fatty acid binding protein in Parkinson's and Alzheimer's disease

Chiasserini, D., Biscetti, L., Eusebi, P., Farotti, L., Tambasco, N., Calabresi, P., & Parnetti, L. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.10.037 · Cited by 1 · see citing works